Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Compound trial record
Compound · clinical trials

Stannous Fluoride Dentifrice clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 3 trials in our USA register that name Stannous Fluoride Dentifrice as an intervention. Synced 10 Nov 2026
3Current trials
0Recruiting now
2Lead sponsors
1Country register
At a glance

Stannous Fluoride Dentifrice is named as an intervention in 3 current clinical trials in our USA register. None are recruiting at the moment. The most common phase is Phase 4. The sponsor with the most trials is Procter and Gamble (2). The most-studied condition is Gingivitis.

Patient leaflets for Stannous Fluoride Dentifrice

The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.

  • UK
    United Kingdom: Search MHRA Products
    Patient information leaflets and SmPCs for UK-licensed products.
  • US
    United States: Search DailyMed
    FDA-approved labels, including patient and medication guides.

Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.

Trials by status

  • Active, closed267%
  • By invitation133%

Trials by phase

  • Phase 4267%
  • Phase 1133%
01

Clinical trials of Stannous Fluoride Dentifrice

3 trials
StudyPhaseStatusLead sponsorRegisters
Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With Diabetes
NCT07619729 · Diabetes Type 2, Periodontal Disease, Caries
Phase 4 By invitation Colgate Palmolive USA
Assessing Gingivitis and Plaque From a Marketed Toothpaste
NCT07158112 · Gingivitis
Phase 4 Active, closed Procter and Gamble USA
Evaluating Gingivitis and Systemic Biomarkers
NCT06962956 · Gingivitis
Phase 1 Active, closed Procter and Gamble USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied with Stannous Fluoride Dentifrice

4 conditions
Gingivitis2Diabetes Type 21Periodontal Disease1Caries1
03

Sponsors

lead sponsor per trial
Lead sponsorTrials
Procter and Gamble2
Colgate Palmolive1
04

By country register

RegisterTrialsRecruiting
Clinical trials in USA30

A trial with sites in more than one country appears in each of those registers.

05

Related compounds

06

Questions about Stannous Fluoride Dentifrice trials

How many clinical trials are testing Stannous Fluoride Dentifrice?

3 current trials in our USA register name Stannous Fluoride Dentifrice as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.

Are Stannous Fluoride Dentifrice trials recruiting patients?

Not at the moment. None of the 3 trials in our registers is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.

Who sponsors Stannous Fluoride Dentifrice clinical trials?

Procter and Gamble (2) and Colgate Palmolive (1). The number in brackets is how many trials each organisation leads.

Where does this information come from?

Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Stannous Fluoride Dentifrice works or whether it is effective, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Stannous Fluoride Dentifrice works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Stannous Fluoride Dentifrice (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.